Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care February 20, 2026
- Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026
- Cell and Gene Therapy at a Turning Point January 30, 2026
- Sepsis Gap & Home Testing Growth: Interview with Kalorama Information’s Daniel Granderson January 9, 2026
- What Is the Size of the IVD Market in 2025? September 8, 2025
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Watch the Companies That Make Cell and Gene Therapies For Pharma, Says New Report
There’s much talk about cell and gene therapy but a new report from a leading market research firm says that there’s a growing market over nearly two billion dollars for companies that make the cell and gene therapies. In 2020, the total global cell and gene therapy BCMO market reached $1,842 million. Over the following […]
Global Biomarker Test Product Sales to Reach $63 Billion in 2027
Total global sales of biomarker test products are projected to reach nearly $63 billion in 2027 with the majority of sales coming from the United States, Western Europe, and Japan, according to new data by leading medical market research publisher Kalorama Information in the report The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, […]
Global IVD Procedures to Grow to 111.3 Billion Annually…Here’s Why
There are currently 76.1 billion in vitro diagnostics (IVD) procedures annually worldwide. Global IVD procedure volumes are forecast to grow by several billion more through 2025, as revealed in IVD Procedure Volumes 2020-2025: Immunoassays, POC, Chemistry, Molecular, Microbiology and Other Tests, a recent report by Kalorama Information. IVD procedures range from glucose to procedures including […]
FDA Approves Novel Cell Therapy for Multiple Myeloma
Modern developments in cell and gene therapy products are transforming the treatment of cancers and genetic diseases, and in the process they have helped create a multi-billion dollar global industry that is poised to more than double over the next ten years, according to 2020 estimates by leading medical market research firm Kalorama Information as […]
COVID-19 Diagnostics Market Reaches 32.5BN in 2022. Antigens. Long COVID-19 Driving Spending. Qiagen, Cue Health Other News
Hundreds of Tests on The Market, U.S. Labs Mostly Use Ten
As the COVID-19 crisis surfaced in the United States, molecular diagnostic manufacturers went to work with new RT-PCR testing kits. There have been hundreds of tests on the market receiving EUAs from the Food and Drug Administration, but a survey from the Association of Molecular Pathology demonstrated that only a few are used by laboratories. As part of its survey: https://www.amp.org/advocacy/sars-cov-2-survey/ labs were asked their top ten testing methods. Among them: Abbott m2000, Roche cobas were the top two vendors in most labs’ top tens.
Roche GenMark Deal – COVID-19 Makes Respiratory Segment and mPOC More Valuable
A recent deal in the news cements the viability of the respiratory segment and the use of small molecular systems to test for them. First introduced in 2013, PCR and other NAAT-based molecular systems have become a central part of testing for ailments such as flu, strep, RSV and COVID-19. They remain in competition with […]
IVD Procedures – 76.1 Billion Annually and Growing
There are currently 76.1 billion in vitro diagnostics procedures annually. Procedure volumes will grow to 111.3 billion in 2025.The chart below depicts the current global estimate and forecast of IVD procedures, including glucose and excluding COVID-19. Population, aging, insurance levels and new test development are factors in the growth of procedures. Global volumes of […]
Molecular Point of Care Test Market Nearly Triples in One Year, Due to COVID-19.
Molecular systems that can test at the point of care was always expected to be a factor in COVID-19. Last year, when our report published, the novel coronavrius was limited in most news accounts to a disease affecting Wuhan, China, we said this: “As presented, the revenues for this segment are forecast to increase from […]
COVID-19 Pandemic Accelerates Adoption of Diagnostic Testing at Point of Care
From Lab Pulse , a sister publication to Kalorama Information – www.labpulse.com Experience with COVID-19 has cast a bright light on the state of healthcare and the great need for change, which has already begun, said panelist Rahul Dhanda, co-founder and CEO of Sherlock Biosciences, a pioneer in diagnostics based on CRISPR gene editing technology. […]
Science and Medicine Groups Predictions for 2021 in the Lab Instrumentation, Diagnostics and Imaging Industries
The unpredictable events of 2020 might cause one forswear all prediction-making. Yet for Science and Medicine Group, the publishing brands we offer (Strategic Directions International, Bioinformatics, Kalorama Information, IMV, Instrument Business Outlook) are in the business of prediction-making. Thus once again, we offer our top ten predictions for 2021 based on our market research publications: Recovery in […]